Skip to content

Clinical trials

Observational Fever trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fever Phase: Observational Clear all

141 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20054
20063
20072
20088
20093
20109
20114
20127
20133
20143
20158
201610
20176
20189
20196
20209
202110
20227
20239
20244
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83
Unknown status25
Recruiting14
Withdrawn6
Terminated6
Not yet recruiting3
Active, not recruiting2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assaf-Harofeh Medical Center6
Assistance Publique - Hôpitaux de Paris4
Institute of Tropical Medicine, Belgium4
MeMed Diagnostics Ltd.4
National Institute of Allergy and Infectious Diseases (NIAID)4
Centre Hospitalier Universitaire, Amiens2
Chinese University of Hong Kong2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Foundation for Innovative New Diagnostics, Switzerland2
Janssen Korea, Ltd., Korea2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fever141
Bacterial Infections12
Infections10
Cough8
Malaria8
Neutropenia8
Dengue7
Disease7
Virus Diseases7
Pneumonia6

Trials

Showing 51 to 75 of 141. Each trial links to its page on Pharma Observatory.

41 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.